Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
 BACK TO LIST

European Patient Summary

Patient
Name: Harrison, , Roy,
DOB: 02-OCT-1969 (Age: 56)
Gender: male
ID: 7093-553922-4 (ECI)
Author
Dr. Ping, Hel
Patient summary Document
European Patient Summary
Report Date: 22-APR-2025

Problem list

Condition Onset Date Status
Hypertriglyceridemia 11-Dec-2001 active
Type 2 diabetes mellitus 05-Dec-2000 active
Essential hypertension 05-Dec-2000 active
Metabolic syndrome X 05-Dec-2000 active
Anemia 05-Dec-2000 active
Gout 09-Mar-1994 active

Medication list

Medication Since Form Dosage Reason
Lisinopril 10 mg oral tablet 2025-04-22 - 1 tablet (10 mg) by mouth once daily Essential hypertension (disorder)

Immunizations list

Vaccine Date
Influenza virus antigen only vaccine product 22-Apr-2025
SARS-CoV-2 mRNA vaccine 23-Mar-2021
Clostridium tetani toxoid antigen adsorbed only vaccine product 13-Mar-2018
Live attenuated Human alphaherpesvirus 3 only vaccine product 13-Mar-2018

Procedure History list

Procedure Date Reason
Pre-discharge assessment 13-Jun-2022 -
Discharge from skilled nursing facility (procedure) 13-Jun-2022 -
Nursing care/supplementary surveillance 12-Jun-2022 -
Occupational therapy 10-Jun-2022 -
Care regimes assessment 08-Jun-2022 -
Professional / ancillary services care 07-Jun-2022 -
Speech and language therapy regime 15-May-2022 -
Physical therapy procedure 02-May-2022 -
History AND physical examination 20-Apr-2022 -
Initial patient assessment 20-Apr-2022 -
Development of individualized plan of care 20-Apr-2022 -
Radiography of ankle 10-Mar-2016 -
Bone immobilization 10-Mar-2016 Fracture of ankle

Allergies and Intolerances

Allergy/Intolerance Onset Date Status Type Reaction
? active ?

Care Plan

Active Planned Care / Goals Start Date Reason
Lifestyle education regarding hypertension 05-Dec-2000 Essential hypertension (disorder)
  • Maintain blood pressure below 130/80 mmHg through lifestyle modifications.
  • Reduce body weight by 5% to improve blood pressure control.
  • Limit sodium intake to less than 2.3 grams per day to help control blood pressure.
  • Engage in at least 150 minutes of moderate-intensity aerobic physical activity per week.
Diabetes self management plan 05-Dec-2000 Diabetes mellitus type 2 (disorder)
  • Maintain or reduce hemoglobin A1c to individualized target to optimize glycemic control.
  • Maintain fasting blood glucose within recommended range to support diabetes control.
  • Maintain blood pressure below recommended threshold to reduce cardiovascular risk in diabetes.
  • Maintain LDL cholesterol below recommended threshold to reduce cardiovascular risk.
  • Achieve and maintain weight reduction to support glycemic control and overall health.
Musculoskeletal care 09-Mar-1994 -

Vital Signs

Vital Signs 2025-04-22 2024-04-16
Body Height 180.6 cm 180.6 cm
Pain severity - 0-10 verbal numeric rating [Score] - Reported 1 {score} 3 {score}
Body Weight 91.2 kg 91.2 kg
Body mass index (BMI) [Ratio] 28 kg/m2 28 kg/m2
Diastolic Blood Pressure 94 mm[Hg] 94 mm[Hg]
Systolic Blood Pressure 129 mm[Hg] 131 mm[Hg]
Heart rate 65 /min 81 /min
Respiratory rate 13 /min 14 /min

Relevant diagnostic tests/laboratory data

Recent Lab Observations 22-APR-2025 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 7.0 H 4.6 - 6 %
Glucose [Mass/volume] in Blood 114.5 H 70 - 99 mg/dL
Urea nitrogen [Mass/volume] in Blood 15.6 7 - 50 mg/dL
Creatinine [Mass/volume] in Blood 1.0 0.9 - 1.3 mg/dL
Calcium [Mass/volume] in Blood 8.6 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 137.9 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 5.0 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 102.3 98 - 114 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 25.5 22 - 32 mmol/L
Cholesterol [Mass/volume] in Serum or Plasma 215.3 H 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 183.1 H 0 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 134.9 H 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 43.8 40 - 60 mg/dL
Microalbumin/Creatinine [Mass Ratio] in Urine 8.3 0 - 30 mg/g

Device Use

Device Date (since)
Blood glucose meter (physical object) 05-Dec-2000